Technology
Health
Biotechnology

Adynxx

$2.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.23 (11.39%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can watch Adynxx and buy or sell other stocks, options, ETFs, and crypto commission-free!

About

Adynxx, Inc. Common Stock, also called Adynxx, is a clinical stage biopharmaceutical company. Read More It engages in the manufacture, development, and sale of novel, disease-modifying products for the treatment of pain and inflammation. The company was founded by Julien Mamet in October 2007 and is headquartered in San Francisco, CA.

Employees
6
Headquarters
San Francisco, California
Founded
2007
Market Cap
1.69M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
72.78K
High Today
$2.35
Low Today
$2.02
Open Price
$2.02
Volume
5.33K
52 Week High
$11.67
52 Week Low
$1.92

Collections

Technology
Health
Biotechnology
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.